An alternative DNA damage pathway to apoptosis in hematological cancers

Although hematological cancers are genomically unstable, the mechanisms by which they evade DNA damage-induced cell death are largely unknown. A current study has revealed that the Hippo signaling pathway transcriptional regulator YAP1 activates an ABL1/p73-mediated proapoptotic effect in response to DNA damage, suggesting that YAP1 has a tumor suppressor function and that the Hippo pathway is a potential therapeutic target in human cancers.